Clinical trials recruiting for Cirrhosis

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• 3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
  NCT06205992 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients
  NCT03472157 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer
  NCT06658782 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Adverse Outcomes and Mortality in Liver Transplant
  NCT05477277 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Affect of Melatonin on Sleep and Cognition in Cirrhosis
  NCT07046429 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
  NCT07521332 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Blood Collection Biorepository for Liver Disease Research
  NCT03025074 · Phase: Not specified · Ages: 7 Years and older · Sex: All (male and female) · 2 locations
• CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound
  NCT06861075 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders
  NCT06594783 · Phase: Phase 4 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)
  NCT05797649 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
  NCT07322237 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• EUS Guided Portal-systemic Pressure Gradient Measurement
  NCT04633356 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG
  NCT06863012 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension
  NCT06687265 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
  NCT07461532 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
  NCT07461545 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants
  NCT06544863 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)
  NCT07424963 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
  NCT05463796 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Indicators Affecting PVT Recanalization
  NCT07473375 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
  NCT05832229 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 13 locations
• Microplastics, Cirrhosis and Portal Hypertension
  NCT07280390 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
  NCT06316869 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
  NCT04371042 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
  NCT06306963 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis
  NCT06932783 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
  NCT06549673 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• TIPS With or Without BCAA
  NCT07281846 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
  NCT07462091 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Cirrhosis often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Cirrhosis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.